ConceptBio & Neuro
Standard of care biomarker testing DLBCL
Testing required for clinical trials and standard clinical treatment of diffuse large B-cell lymphoma to determine cell of origin, double expressor status, and therapy options.
Know first
Named as a prerequisite by the lectures that define this. The number is how many say so. A grey one has no page yet.
Cytogenetics1Diffuse large B-cell lymphoma1
Lecturers
1Connections
2The lectures that define it or assume it, and the concepts next to it.